We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Early-Onset Sepsis Rates in Newborns Determined

By LabMedica International staff writers
Posted on 28 Apr 2011
Current early-onset sepsis rates among newborns, the pathogens involved, and associated morbidity and mortality were determined in the United States.

The multisite national study demonstrated that the most frequent pathogens associated with sepsis were group B streptococci (GBS) in full-term infants and Escherichia coli in preterm infants.

Nearly 400,000 newborns were included in the study, which also found that infection rates increased with decreasing gestational age and birth weight. The overall rate of infection was 0.98 per 1,000 live births; 0.41 per 1,000 live births involving GBS and 0.28 per 1,000 live births involving E. coli.

Bloodstream infections in newborns can lead to serious complications with substantial morbidity and mortality. The pathogens responsible for neonatal infections have changed over time. In recent years, however, antibiotic prophylaxis given to at-risk mothers has reduced the incidence of early-onset group B streptococcal infections among their babies.

"Infections occur in almost one case per thousand live births," said Barbara Stoll, MD, lead investigator for the study. Prof. Stoll is the George W. Brumley, Jr., professor and chair, Department of Pediatrics in Emory University School of Medicine (Atlanta, GA, USA). "With approximately 4 million births a year in the United States, this equates to a substantial burden of disease. We estimate that approximately 3,000 infants a year develop early-onset sepsis. With current mortality rates, approximately 300 to 350 deaths per year are associated with neonatal sepsis. So, it's not inconsequential."

The study also shows that opportunities for prevention of neonatal GBS infections continue to be missed. "Missed opportunities for prevention of GBS include failure to screen all women who deliver at term, failure to provide antibiotics to all colonized women or to those who delivered preterm with unknown colonization status, and false negative GBS screens among women who deliver with GBS infection," added Prof. Stoll.


The study appeared online on April 25, 2011 and in the May 2011 issue of Pediatrics.

Related Links:

Emory University School of Medicine




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N

Latest Microbiology News

New Test Diagnoses Bacterial Meningitis Quickly and Accurately
28 Apr 2011  |   Microbiology

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
28 Apr 2011  |   Microbiology

New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
28 Apr 2011  |   Microbiology